| Schedule of Stock-Based Compensation Expense |
Stock-based compensation included in the Condensed Consolidated Statements of Operations and Comprehensive Loss is as follows (in thousands):
| | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended September 30, | | Nine Months Ended September 30, | | 2024 | | 2023 | | 2024 | | 2023 | | Cost of revenue | $ | 2,033 | | | $ | 21,902 | | | $ | 7,032 | | | $ | 21,945 | | | Selling and marketing | 8,519 | | | 95,962 | | | 29,978 | | | 96,141 | | | Research and development | 11,505 | | | 104,829 | | | 37,679 | | | 105,642 | | | General and administrative | 9,500 | | | 77,282 | | | 26,001 | | | 78,589 | | | Stock-based compensation, net of amounts capitalized | 31,557 | | | 299,975 | | | 100,690 | | | 302,317 | | | Capitalized stock-based compensation expense | 881 | | | 1,217 | | | 2,818 | | | 1,217 | | | Total stock-based compensation expense | $ | 32,438 | | | $ | 301,192 | | | $ | 103,508 | | | $ | 303,534 | |
|